CryoValve SG Pulmonary Human Heart Valve Post Clearance Study (SGPV)
Sponsor: CryoLife, Inc.
A observational or N/A phase clinical study on Aortic Valve Insufficiency and Aortic Valve Stenosis, this trial is completed. The trial is conducted by CryoLife, Inc. and has accumulated 10 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 5 earlier versions
-
Mar 2022 — Dec 2022 [monthly]
Completed
-
Jan 2021 — Mar 2022 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CryoLife, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .